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BINDING DOMAIN ANALYSIS OF PHAGE DISPLAY SELECTED 
PEPTIDES 
 
SUMMARY 
Genetically engineered peptides with specific affinity for inorganic surfaces have the 
potential to be used as linkers and major building blocks for self-assembly of 
materials with controlled organization and specific functions. Phage display 
technology is adapted for the selection of inorganic surface specific proteins. An 
understanding of mechanism of surface interactions is necessary to control peptide 
building.  
Protein domains are indepently folding units that represent a small number of 
polypeptides that creates a specific, 3D structure that leads to a desired interaction. In 
genetic engineering, it is essential to know the specific amino acid residues within 
the domain that directly bind polypeptides to their substrates. By identifying the 
conserved positions of amino acids, those necessary for stabilization and function 
can be determined.  
The main focus of this study is to vary the functional capacity of the peptide chain 
through site directed mutagenesis to determine a core set of amino acids that is 
responsible for binding to a chosen inorganic surface. This task is accomplished 
using phage display selected peptides for platinum and palladium via site directed 
mutagenesis protocols, once they are displayed on phage. In particular, the 
modification of serine and threonine residues is carried out with respect to their 
neutral counterparts to reveal a possible role in their binding sequences. Mutants 
were constructed by a PCR based site directed mutagenesis procedure. Binding 
characterization of the cloned phages are assessed by fluorescence microscopy (FM) 
and enzyme-linked immuno sorbent assay (ELISA) to understand the mechanism of 
noble metal binding. The consequences of this study can be used in understanding of 
the binding domain of the peptides in their specific interactions with the inorganic 
surfaces. Smart peptides with selectivity can also be constructed and practiced in 
bionanotechnological applications. 
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FAJ GÖSTERİMİYLE SEÇİLMİŞ PEPTİDLERİN BAĞLANMA 
BÖLGELERİNİN ANALİZİ 
 
ÖZET 
İnorganik yüzeylere seçici özgüllüğü olan genetik olarak değiştirilmiş peptidler, 
malzemelerin kendiliğinden oluşturulmasında, kontrollü organizasyon ve özel 
fonksiyonlar için bağlayıcı molekül ve yapı taşları olarak kullanılabilme 
potansiyeline sahiptirler. Faj gösterim teknolojisi inorganik yüzeylere özgül olarak 
bağlanabilen peptidlerin seçilebilmesi için adapte edildi. Yüzey etkileşimlerinin 
mekanizmasının anlaşılabilmesi, peptid yapılanmasının kontrolü için gereklidir.  
Protein bölgeleri, bağımsız bir şekilde katlanabilen ve istenilen etkileşimi 
sağlayabilecek özgül 3 boyutlu yapının oluşmasını sağlayan küçük polipeptidleri 
ifade eder. Gen mühendisliği alanında, bölge içersinde bulunan ve polipeptidlerin 
substratlarına doğrudan bağlanmasından sorumlu özel amino asitleri bilmek 
gereklidir. Amino asitlerin korunmuş pozisyonlarını belirleyerek, stabilizasyon ve 
fonksiyon için gerekli amino asitler de belirlenebilir.   
Bu çalışmanın asıl odak noktası site directed mutagenez yöntemleri kullanarak 
peptidin fonksiyonel kapasitesini değiştirmek ve bu şekilde de seçilmiş belirli bir 
inorganik yüzeye bağlanmaktan sorumlu amino asit gruplarını bulmaktır. Bu görev, 
faj gösterim metodu ile seçilmiş platin ve paladyuma özgül olarak bağlanabilen 
peptidlerin, site directed mutagenez yöntemi ile peptitler faj üzerinde ekspres 
edildiğinde gerçekleştirilmiştir. Özellikle, serin ve treonin amino asitlerini, bunlara 
karşılık olarak gelen nötr amino asitler ile değiştirerek, bu amino asitlerin bağlanma 
üzerindeki etkilerinin ortaya çıkarılması amaçlanmıştır. Değiştirilmiş mutantlar, PCR 
tabanlı site directed mutagenez prosedürü ile oluşturulmuştur. Klonlanan fajların 
bağlanma karakterizasyonları florasan mikroskobu (FM) ve enzim-bağlı immün 
essey (ELISA) yöntemleri ile tayin edilerek asal metallerin bağlanma mekanizmaları 
anlaşılmaya çalışılmıştır. Bu çalışmanın sonuçları, inorganik yüzeylere özgül olarak 
etkileşime geçen peptidlerin bağlanmadan sorumlu bölgelerinin anlaşılması için 
kullanılabilir. Biyonanoteknolojik uygulamalar için “seçiciliğe sahip akıllı 
peptitlerin” oluşturulması ve denenmesi de gerçekleştirilebilir.    
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1. INTRODUCTION 
1.1. Proteins and Their Roles in Biological Systems and Materials 
When we investigate a cell with physical or chemical analysis methods, we always 
face with the same macromolecules. In fact, they can be in anywhere and in any 
suitable role for showing their activity and ability in the cell. These macromolecules 
are called as proteins.  
“Protein” word came from the Greek word, protas, as the meaning of “primary 
importance”. But then, what is the secret of being so important in the cell? The 
answer lies under the structural properties of proteins.  
Three-dimensional conformation of the proteins gives them their functional 
properties and capacity. An important feature for proteins is that they spontaneously 
fold into very well-determined, selective and elaborate three-dimensional structures, 
which are configured by the amino acid residues they consist of. This self-folding 
ability of proteins provides the passage from one-dimensional sequence information 
to three dimensional biological functions [1]. 
 “Building blocks of the organism” term is mostly referred to proteins. Actually, 
proteins constitute most of a cell dry mass. They are not only the building blocks 
from which cells are built, but also execute nearly all cell functions. Enzymes, 
catalizer protein molecules, serve as the proper molecular surface supplier and 
promoters for the chemical reactions to take place in the cells. Protein made channel 
pumps enclosed in the plasma membrane are important in the control of transfer into 
and out of the cell. Some of the proteins have significance in signal transduction 
mechanisms. Also, for immune response and protection cells from extreme 
environmental conditions or outer effects, proteins are used by the immunity system 
of the organism. In DNA level, the importance of the proteins is getting higher like 
their role in the stabilization of DNA. All these variable properties of proteins rely on 
the fact that they are highly specific and selective towards their ligands [1, 2]. Some 
important protein based molecules can be seen in Figure 1.1. 
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Figure 1.1. 3D structure of three important protein based molecules. (a) DNA polymerase 
beta (pol beta) (E.C.2.7.7.7) complexed with six base pairs of DNA [4]. (b) Lysozyme 
(E.C.3.2.1.17) [5]. (c) Hemoglobin (T-state, deoxygenated) [6]. 
The biological properties of protein molecules depend on the physical interactions 
with other molecules. All proteins bind to other molecules, however, this binding can 
be tight in some cases and weak and short-lived in others. In all of these cases, one 
thing is always the same: Great specificity. With this ability, protein will selectively 
bind its ligand while there are too many other molecules in the molecular 
environment. The ability of a protein to bind selectively and with high affinity to its 
ligand depends on the formation of both bonding and nonbonding interactions and 
their combinations. Not only the surface residues are important in binding of proteins 
to their ligands, but also the atoms buried in the interior of the protein which have no 
direct contact with the ligand, provide an essential scaffold giving the surface its 
chemical properties. Even small changes to the amino acids in the interior of a 
protein molecule can change its three-dimensional conformation enough to destroy a 
binding site on the surface [1-3]. 
Through this uniqueness and specificity, proteins, the building blocks of the cell, take 
place in tissue engineering, as well. Proteins take role in forming complex nano 
structures in soft (muscle, skin, tendon, membrane, silk of spider) and hard (bones, 
dental tissues, spicules, spines, shells, skeletal units of single-celled organisms or 
plants, bacterial thin film, nanoparticles) tissues [7, 8]. Soft tissues contain only 
proteinaceous phase whereas hard tissues contain both at least one proteinaceous and 
inorganic phase [8-10]. By genetic control, hard and soft tissues are synthesized in 
organisms when the organism needs them in necessary conditions and aqueous 
environment [7-10]. 
Figure 1.2 shows examples of organic-inorganic hybrid material formations in some 
organisms. By using protein – inorganic interactions, all these hybrid systems are 
a b c
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naturally produced in organisms which have naturally found the ways to use some of 
their proteins to produce and bind the inorganic materials and then use these 
magnificent systems for their need. The products of these systems can be used in 
such as forming protective layers, supportive tissues, transferring charge and ion, 
developing some optical and mechanical properties [8, 9, 11]. 
 
Figure 1.2. Examples of biologically synthesized organic-inorganic hybrid materials: (a) 
Single-crystalline, single-domained magnetic magnetite nanoparticles (Fe3O4) formed by a 
magnetotactic bacterium (Aquaspirillum magnetotacticum) (inset: higher magnification 
image of the magnetite nanoparticles revealing cubo-octahedral particle shape). (b) S-layer 
bacterium, Synechococcus strain GL24, has a nanostructurally ordered thin film calcite on its 
outer layer serving as a protective coating. (c) Hard, wear-resistant tooth enamel of mouse 
consists highly ordered micro/nano architecture of hydroxyapatite crystallites that assemble 
into a woven rod structure (SEM image). Each rod is composed of thousands of 
hydroxyapatite particles (inset: cross-sectional image of a mouse incisor; white region is 
enamel, backed by grayish dentine) [12]. 
1.2. Inorganic Binding Polypeptides 
Inspiration from nature and using this with biology, we can now construct hybrid 
materials with molecular biology tools and nanotechnology. This combination is 
referred as “molecular biomimetics”. Molecular biomimetics shortly searches for 
polypeptides which recognize and specifically bind to inorganics to form the hybrid 
systems. In this manner, formation and assembly of functional inorganic hybrid 
materials and systems can be controlled for the construction of biolinkers and 
molecular building blocks [12]. 
 
 
 4
1.2.1. Obtaining inorganic binding polypeptides 
There are some classical techniques that are used to create nano–technological 
systems, but these techniques have some drawbacks like requiring high temperature, 
pressure and pH adjustment and production of toxic byproducts [12]. Also, obtaining 
desired size nano particles can be difficult with these methods. However, when we 
look at the nature, these problems have been already overcome.  
Up to now, only a few proteins have been characterized well to bind inorganic 
materials such as ice binding (antifreeze) proteins in some fish, plant and insect 
species [13]. Other than ice-binding protein, the organisms in Figure 1.2 have 
organic-inorganic hybrid systems where an inorganic- binding peptide relationship 
has occurred. Some of the proteins in these organisms are used to form inorganic 
material in vivo and then the organism uses these inorganics for its benefit. 
Isolation and determination of the specific inorganic binding proteins consist of 
several possible ways. One of these ways is the extraction the proteins from related 
tissues [11, 14]. However, extraction of proteins and cloning of their genes is 
complicated and time consuming. Also, number of determined and characterized 
proteins is limited [15]. Inorganic binding proteins can be designed with [16] 
molecular approach which is similar used in pharmaceutical drug research but it is 
time consuming and expensive method like extraction methods [11, 14]. 
To overcome these problems, molecular libraries or combinatorial libraries which are 
generated completely random sequences of peptides or oligonucleotide is used. 
Combinatorial biology libraries are composed of same number of amino acids coding 
insertion but composition of different sequences. They have been used to screen and 
identify various biological activities, such as catalytic properties or altered affinity 
and specificity to target molecules in many applications including the design of new 
drugs, enzymes, antibodies, DNA-binding proteins and diagnostic agents [17-19]. 
Combinatorial biology techniques have also some limitations like requirement of 
complex polypeptide production and need to have many chemical reactions [14, 20, 
21]. However, display technologies can improve these disadvantages. Although this 
limitations, phage display (PD) and cell surface display (CSD) techniques in vivo are 
adapted for selection of inorganic binding polypeptides [20, 22]. These techniques 
consist of a large, random library of peptides with the same number of amino acids, 
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but of different sequence compositions, are screened to identify specific sequences 
that strongly bind to a target inorganic material surface [17, 23, 24]. In this method 
there is no need to have some information about the polypeptides sequence which is 
specific to the selected material. 
Till now, PD has been performed to isolate sequences binding to silica [24], silver 
[26], gallium arsenide [23], zinc sulfide [28], calcite [29], cadmium sulfide [30] and 
noble metals such as platinum and palladium [31] where CD has been used for 
investigation of peptides that recognize gold [12], zinc oxide [32], iron oxide [12,33], 
zeolites [32] and cuprous oxide [32]. 
1.2.2. Phage display technique 
The display of a protein or peptide on the surface of a bacteriophage particle –phage 
display- is an efficient in vitro technique that involves insertion of the corresponding 
DNA into the gene of a structural protein and the expression of the foreign sequence 
as a fusion with the structural protein that is “displayed” on the surface of the phage 
particle [19]. This technique enables the selection of polypeptides with desired 
binding specificities and properties among a large collection due to the ability of 
certain phage allows additional peptide sequences to be incorporated into the coat 
proteins without disrupting their structure and function by linking the DNA sequence 
encoding the protein and the peptide itself. Thereby a direct link is constructed 
between phenotype and genotype [19, 35, 36]. 
There are many vector options for phage display. One of these alternatives, that is 
widely used, is bacteriophage M13 (Ff family). Bacteriophage M13 genome is easily 
manipulated and high titers can be obtained. However, the peptide size that is wanted 
to be displayed is limited. This disadvantage is tried to be overcome by using other 
vector types like phage λ, T7 or T4 [37, 38]. 
1.2.2.1. Phage display peptide libraries 
Biological molecules that are active against other biological molecules and 
specifically interact with them can be distinguished in a vast population of randomly 
generated sequences. This principle can be used in discovery of ligands for certain 
proteins and peptides. This is mainly achieved through the insertion of random DNA 
fragments to the amino-terminal portions of structural coat proteins on viruses [39]. 
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Peptide libraries generated in this way consist of a high number of peptides of a 
particular length, whose sequences are random and hence the amino acid residues are 
varied at each position. The peptides in some libraries also have fixed residues that 
provide formation of secondary structures such as disulfide bridged loops and alpha 
helices [40].  
All five coat proteins can be used to display peptides or proteins for M13 
bacteriophage case. Variety of the insertion site and length can be used as 
construction of different phage display libraries. g7p and g9p minor coat proteins are 
used in N-terminal display [41] and g6p is used for C-terminal display [42] whereas 
both C-and N-terminal display can be achieved with g3p and g8p [35, 43, 44].   
Table 1.1. M13 coat proteins with their amino acid numbers, molecular weights, copies per 
phage and peptide fusion site [35]. 
 
N-terminal based fusions mostly depend on g3p and g8p usage for the generation of 
phage display libraries. The limitation is that only short peptides (6-8 residues) can 
be displayed in every copy of major coat protein g8p. Due to the size restrictions of 
the channel through which phage ssDNA pass during assembly, larger peptides than 
8 residues can be displayed only on 10 % of the coat proteins. 
g3p, the minor coat protein, is more tolerant for large insertions and short peptides 
can be monovalent displayed without interfering with the phage infectivity to 
generate library [35, 43, 44]. 
Cyclic or “constrained” libraries encode the insert sequence between two cysteines. 
The idea behind the cyclic library is to constrain the peptide so that it assumes fewer 
conformations. Thus, if the library contains a good binder, it will be in the correct 
formation for binding more frequently than a floppy linear molecule. A cyclic 
peptide is easier to model using computational methods because there are fewer 
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degrees of freedom within a fixed loop than a floppy linear peptide. However, the 
disulfide constraint may “freeze out” a conformation required for target binding [43, 
44]. 
As a summary, peptide libraries can be constructed by inserting 5-38 amino acid long 
peptides but increasing length of peptides may affect the display efficiency and 
phage viability.  
1.2.2.2. M13 filamentous bacteriophage 
Bacteriophage M13 is a filamentous virus belongs to the virus family of Inoviridae 
which encapsulate their circular single stranded DNA inside the proteinaceous coat. 
The length of the virus majorly depends on the size of the genetic material but it 
ranges between 0.7 and 2 µm and surprisingly with a diameter of 6-7 nm. The 
filamentous phage infects Escherichia coli. M13 phage assembly is a non-lytic and 
membrane associated process. Even at a slow rate, the phage particles continue to 
grow and released from E.coli without lysing the cell.  
The genetic material of M13 bacteriophage is composed of single stranded circular 
DNA form (Figure 1.3). The M13 genome contains 6400 nucleotides and 11 genes, 
five of which are responsible for encoding phage coat proteins while others encode 
proteins used for replication and assembly of the virus [35]. 
 
Figure 1.3. M13 genome [43]. 
The M13 filamentous coat is a symmetric array of several thousands of α-helical 
major coat P8 proteins which surrounding DNA core. Of minor coat proteins, 
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protein-7 and protein-9 cap one end while protein-3 and protein-9 cap the other end. 
There are about 5 copies of each minor protein per particle (Figure 1.4) [35, 46].   
 
 
Figure 1.4. (a) A diagram of the bacteriophage particle shows the single-stranded DNA core 
surrounded by a proteinaceous coat [35]. (b) Structure of M13 bacteriophage and distribution 
of coat proteins [47]. 
All of these major and minor proteins have important roles in structural stability of 
the phage particle; pVI which works in the termination of the assembly process, pVII 
which is required for initiation of assembly, pIX which is involved in maintenance of 
virion stability. pIII is also a key factor for host cell recognition and infection. 
a 
b
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Beyond this, pIII is the largest structurally most complex one among coat proteins 
with three different domains.    
Several thousand copies of pVIII protein are available in each phage particle. The 
insertion of the sequences for phage display is done at the N-terminus, between 
signal sequence and protein coding sequence. The sequence accepts only short 
peptides (6-8) for display, for longer sequences, packaging of the phage particles is 
prevented. For most phage display fusions, the favorite protein pIII because of its 
tolerance for large insertions, compatibility with monovalent display and availability 
of vectors [36]. 
The N-terminal domain of the pIII protein starts the translocation of the phage DNA 
into the host cell while second domain is responsible for the recognition of the host 
cell and adsorption to the F pilus on E.coli cell surface. On the other hand, C-
terminal domain of the pIII deals with other phage coat proteins, so that it is 
responsible for the integration of pIII into the phage coat. The structure of the first 
two domains have been solved by X-ray crystallography and NMR spectroscopy but 
the structure of the third domain and also other coat proteins have not been able to 
enlightened except for pVIII [35]. According to these studies, g3p consists of three 
domains. Two N-terminal domains namely N1 and N2, and one C-terminal domain 
called CT. These three domains are linked with two linker regions consist of a 
glycine-rich sequence [36] (Figure 1.5). 
 
Figure 1.5. Domain structure of g3p [36]. 
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M13 bacteriophage can only infect bacteria that have F pilus. This bacterial structure 
is an extracellular filament and is responsible for the communication between two 
bacteria. Also F pilus is the recognition sites for infectious bacteriophages. Only one 
or a few F-pili are present on the surface of a bacterial cell. Both pilus structural 
proteins and the proteins required for pili assembly are conjugative plasmid encoded 
[48]. 
Filamentous phage infection is a two step process: (i) recognition (which the 
bacteriophage binds to its primary bacterial cell surface receptor and (ii) 
translocation (which involves pilus retraction, capsid protein integration into the 
bacterial cell membrane, uncoating of viral DNA and its translocation into the host 
cell cytoplasm [49]. 
Infection of a male E.coli cell is initiated by binding of the N2 domain of pIII to the 
tip of the F-pilus. When N2 binds to pilus, N1 releases from its normal interaction 
with N2 and N1 domain interacts with the host cell membrane protein Tol A. The 
pilus is retracted by an unknown mechanism (Figure 1.6). This retraction provides 
the interaction between g3p and the cell membrane proteins TolQRA. Then viral 
DNA enters to the cell cytoplasm [50]. 
  
Figure 1.6. The Ff bacteriophage infection process. Pilus mediated separation of N1 from 
N2 at the amino terminus of pIII frees up N1 for interaction with the D3 domain of the 
coreceptor, TolA, thus mediating viral entry into the host cell [50].  
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Filamentous bacteriophages contain a single stranded DNA genome that replicates in 
three stages. In stage I, once the phage (+) strand ssDNA (SS) is translocated into the 
cytoplasm after infection, bacterial host enzymes synthesize the complementary (-) 
strand, producing a double-stranded covalently closed supercoiled DNA product 
called the parental or replicative form (RF) DNA (SS---RF). Stage II occurs when 
the RF DNA replicates to form a pool of approximately 100 RF DNA molecules per 
cell (RF---RF). In the final stage, the RF DNA molecules act as a template for the 
synthesis of progeny single- stranded DNA phage genomes (RF---SS) [36]. 
Transcription of the (-) strand of the RF DNA occurs in a clockwise direction as 
shown in Figure 1.3 and results with gene products produced in the order in which 
they are required for phage production [51]. The gene II protein is an endonuclease-
topoisomerase that introduces a specific nick in the (+) strand of the RF DNA. The 
resulting 3’ end serves as a primer for synthesis of new (+) strands via a “rolling 
circle” mode of replication carried out by host cell enzymes and terminated and 
circularized by pII (Figure 1.7). The resulting (+) strands can either be used as 
templates for the synthesis of more RF DNA or be coated by pV dimmers and 
prepared in the cytoplasm ready to be assembled [40,51]. 
 
Figure 1.7. The “rolling circle” mode of M13 bacteriophage [47]. 
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1.3. Protein Engineering 
Protein engineering is the field of study involving the creation and modifications of 
proteins. Although the playground of protein engineering is very young, the 
applications of it range from creating structural motifs that test theories of protein 
folding and understanding of protein stability, to the production of first and second 
generation products for human therapeutics or industrial products. 
The role of protein engineering deals with catalysis, molecular recognition, protein 
structure, protein folding, protein stability and protein-protein interactions. The aim 
for studying these addressed questions is to target the amino acids which may be 
playing structural or functional roles, deleting or replacing them with alternative ones 
to test the impact of the changed amino acids, hydrophobic forces, electrostatics and 
charge and the placement of hydrogen bonds, salt bridges, disulfide bonds, water or 
metals [52]. 
Up to now, two general approaches have been identified for protein engineering. One 
of them is known as rational design, in which one needs the detailed knowledge of 
the 3D structure and function of the protein to make desired changes. This approach 
has the advantage of being generally inexpensive and easy. However, the structural 
knowledge of a protein is often unavailable. Even the structure is known, it can not 
be predicted the effects of various mutations in the experiment.  
The second approach is known as random approach (directed evolution). Directed 
evolution involves repeated rounds of random mutagenesis. The key element in the 
process is the ability to screen large numbers of mutants. Once the desired mutant is 
identified, it can be isolated. However, because there is no control over the mutations 
made, large numbers of mutations must be analyzed to get practical indications. This 
also has the meaning of labor intensive and long work. 
 1.3.1. Site directed mutagenesis 
Site-directed mutagenesis is a rational approach that has been widely used in studies 
of gene expression and protein structure-function relationships. This method is 
utilized for the modification of protein or enzyme properties by providing the applier 
to change the gene sequence and therefore, the amino acid sequence of an expressed 
protein. The importance of site directed mutagenesis is beyond structure-function 
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relationship, for the techniques allowing the generation of mutant proteins with very 
specific changes in certain amino acids. These kinds of mutations facilitate the study 
of catalysis mechanism, stability in case of harsh conditions and high specificity for 
the substrate [53]. 
There are many methods for site directed mutagenesis. Three of them are mostly 
used. These are cassette mutagenesis, primer extension and PCR-based mutagenesis. 
In cassette mutagenesis method, a synthetic DNA fragment including the wanted 
mutation on a certain sequence is replaced with the matching sequence in the non-
mutated gene. This method is very simple with efficiency almost 100 %. The main 
drawback of the method is that the procedure requires the unique restriction sites 
flanking the region of interest [53]. 
Primer extension method, which is the simplest method of site-directed mutagenesis, 
involves priming in vitro DNA synthesis with a synthetic oligonucleotide carrying a 
base mismatch with its complementary strand. The requirement of the method is that 
the target DNA to be mutated should be in single-stranded form and M13-based 
vectors are the most suitable for these kinds of mutations [54]. Figure 1.8 shows 
basically how this process performs. 
 
Figure 1.8. The flowchart of site directed mutagenesis process. The first applier of this 
method, Michael Smith, has won the Nobel Price in Chemistry 1993 [55]. 
PCR-based site-directed mutagenesis method has a high potential for mutagenesis 
reactions. This method allows the amplification of single stranded, double stranded, 
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circular or linearized mutant DNA. Desired mutations are incorporated into the 
oligonucleotide primers in the form of single base mismatch. Long fragments up to 6 
kbs is possible to amplify and with the less undesired mutations by using 
thermostable DNA polymerases with 3’→5’ proofreading activity. The desired 
mutation is obtained with 100% efficiency in PCR-based mutagenesis method. The 
main drawback of the method is that Taq polymerase copies DNA with low fidelity 
and this may cause undesired mutations on the template [54, 56]. But with the 
synthesis of high fidelity Taq polymerases, this drawback should be eliminated thus, 
high fidelity Taq polymerases have the ability of synthesis of long sequences without 
any nucleotide deficiency. 
Widely usage of site directed mutagenesis forced researchers to find new ideas how 
site directed mutagenesis can be a “piece of cake”. So, other methods for the 
selection and enrichment have been generated. The most common problem is the 
occurrence of the unmutated, template DNA in the mutagenesis reaction with the 
other mutant types after the reaction. This unmutated-mutated mixture makes the 
process more complicated and laborious for searching the mutated ones. To get rid of 
the template DNA, some methods are developed. In the beginning of the site directed 
mutagenesis reaction, parental DNA is methylated with DNA methylase. Thus, in the 
following steps after the mutagenesis reaction, the unmutated DNA can be digested 
by special endonuclease providing from host cell which transformation of reaction 
occurs in. Hence, the amplified DNA sequence will be only the desired ones [57]. 
1.3.1.1. Alanine scanning mutagenesis 
Alanine scanning mutagenesis, systematic replacement of individual wild type 
residues with alanine, is a particularly useful technique for the identification of 
functional epitopes and consequently for uncovering biological insight [58]. This 
method has been applied to identify functional regions on human tissue type 
plasminogen activator, yeast cAMP-dependent protein kinase, human growth 
hormone receptor, human IL-8 and yeast cdc2 [57, 58].  
The technique involves the substitution of each of the charged amino acids such as 
asparagine, glutamic acid, arginine, lysine and histidine in the peptide or protein with 
alanine. The resulting set of mutants can be observed for functional defects to 
identify the important regions. 
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The charged amino acids are selected for mutagenesis because they are more likely 
to be located on the surface of the protein [59, 60]. These residues are capable of 
forming ion pairs and hydrogen bounds. Therefore, they are likely to be important for 
enzyme catalysis and for the recognition of ligands. Alanine was chosen as the 
residue for all substitutions. 
Alanine is the most common amino acid in proteins [61] (Figure 1.9). It is the 
smallest amino acid except for glycine, it is a hydrophobic molecule, it is located in α 
helices, β strands and turn regions and it is distributed amongst the buried and 
exposed residues in proteins [61, 62]. Substitution with alanine removes all side 
chain atoms past the β-carbon and does not change the hydrophobicity. Hence, it 
does not impose electrostatic and steric effects. Therefore, substitution with alanine 
allows the effects of removing the side chain to be evaluated while minimizing the 
chances of distrupting the secondary structures and tertiary conformation of the 
protein as do glycine and proline [63, 64]. 
  
Figure 1.9. The molecular structure and 3D view of alanine amino acid [65]. 
1.4. Studies on Inorganic Binding Peptides 
Peptides or proteins can bind to inorganic surfaces with specifically and selectively. 
The binding surface could be or a well-defined one such as a single crystal or a 
nanostructure, either a rough surface such as a powder. Biocompatible materials 
which are produced under physiological conditions in aqueous environment show 
stable surface structures and compositions. Noble metals such as Platinum (Pt) and 
palladium (Pd), and oxide semiconductors like Cu2O and ZnO are examples to these 
surfaces which are used in experiments using both flagellar and phage display 
methods in our group [10, 66].  
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The specificity of a peptide for an inorganic surface may root from chemical 
recognition mechanisms such as hydrogen bonding, polarity or charge effects, and 
from structural recognition mechanisms such as size and morphology. By using the 
available set of some inorganic binding sequences, some outcomes may be obtained. 
Phage display and flagellar display techniques are used to identify amino acid 
sequences that show high affinity to noble metals and semiconducting oxides. For 
instance, binders of metallic platinum and palladium powders are selected via phage 
display technology in our group [10]. In the display, a random peptide library formed 
by seven amino acids which is fused to bacteriophage M13 minor coat protein (pIII) 
is used. As the peptides were selected, they were categorized according to their 
physicochemical properties such as isoelectric points (pI), charges and molecular 
weights (Table 1.2). 
Table 1.2. Examples of Pd and Pt binding peptides selected from a disulfide-constraint 
phage display peptide library. Color codes of amino acids are given in Appendix A [31]. 
Pd Binder Peptides pI Charge M.W. 
SPRLQGV 9.47 +1 755.87 
TTLNPGT 5.19 0 702.76 
VNSHPPL 6.71 0 762.86 
TLPNHTF 6.40 0 828.92 
SPHPGPY 6.46 - 753.80 
Pt Binder Peptides    
QSVTSTK 8.75 +1 749.82 
PTSTGQA 5.96 0 660.68 
TSPGQKQ 8.41 +1 744.80 
IGSSLKP 8.75 +1 700.83 
Due to the fact that this categorization showed only the importance of the peptides 
for binding to Pt and Pd, but not showed the affinity strength, one of the widely used 
characterization method, fluorescent microscopy has been applied to elucidate the 
binding affinity. 
As a result of some analysis, the selected sequences have shown conserved 
hydrophobicity and hydroxyl containing amino acids, threonine and serine (Table 
1.2) [12, 66]. It has been concluded that hydroxyl groups in side chains of these 
amino acids seemed to play a key role in binding activity of the sequences to metal 
substrates, no matter which structure do the substrates have. The lack of cysteine 
residues in most of the isolated sequences and presence of histidine residues in only 
some sequences have surprising effects because these two residues are believed to 
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bind to metal ions. Further analysis of the presence and location of the certain amino 
acids may give a better angle of sight towards the presence of specific binding 
domains for inorganic materials [66, 67]. 
1.5. Aim of The Study 
In this study, we have recently applied site directed mutagenesis i) to identify the 
core amino acids in phage display selected strong Pt binder SD152 with the amino 
acid sequence of PTSTGQA via alanine scanning approach applied once the peptides 
are on phage, ii) based on the results obtained from platinum binder, to make a 
reverse engineering comparing to the first one, changing glycine amino acid in the 
fifth position to a polar amino acid in phage display selected weak Pd binder SD188 
with the amino acid sequence of SPHPGPY, again when the peptide is displayed on 
phage to observe any effect on enhancement for binding affinity. 
Binding affinity and specificity of constructed mutants has been characterized via 
fluorescent microscopy (FM) and enzyme-linked immunosorbent assay (ELISA) 
analyses. The results have been compared with the unmutated, wild type SD152 and 
SD188. 
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2. MATERIALS AND METHODS  
2.1. Materials 
2.1.1. Bacterial strains 
2.1.1.1. E.coli ER2738 host strain 
F´ lacIq ∆(lacZ)M15 proA+B+ zzf::Tn10(TetR)/fhuA2 supE thi Δ(lac-proAB) 
∆(hsdMS-mcrB)5 (rk – mk – McrBC–) was used as a host for wild type M13 phage. 
This strain was not a competent strain and it was purchased as 50 % glycerol culture 
within Ph.D.-C7C™ Phage Display Peptide Library Kit [68]. 
2.1.1.2. E. coli DH5αTM-T1R host strain  
F- Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rk-, mk+) phoA 
supE44 thi-1 gyrA96 relA1 tonA (confers resistance to phage T1), chemically 
competent cells were supplied with GeneTailor™ Site-Directed Mutagenesis System 
[69,70]. 
2.1.1.3. E. coli DH5αTM-FT host strain  
F- Φ80lacZ Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk-, mk+) phoA supE44     
λ- thi-1 gyrA96 relA1 / F’ proAB+ lacIqZΔ15 Tn10(TetR), chemically competent 
cells were purchased to be used as a host for mutated M13 phages [71].  
2.1.2. Enzymes  
2.1.2.1. Platinum® Taq DNA polymerase high fidelity  
Platinum® Taq DNA Polymerase High Fidelity is an enzyme mixture including 
recombinant Taq DNA polymerase, Pyrococcus species GB-D thermostable 
polymerase that shows proofreading ability with its 3' to 5' exonuclease activity and 
Platinum® Taq Antibody. Presence of a proofreading enzyme in the enzyme mixture 
increases fidelity nearly six folds comparing to Taq DNA polymerase alone and 
allows amplification of complex and long DNA templates up to 20 kb with some 
optimization.  
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Besides, the Platinum® Taq Antibody provides an automatic “hot start” PCR 
condition by binding and inhibiting the polymerase activity that is restored after 
denaturation step in PCR cycling at 94 °C. This programmed “hot start” process 
provides more sensitivity, specificity and yield in PCR [72]. 
2.1.3. DNA molecular weight markers  
2.1.3.1. Lambda DNA/EcoRI+HindIII marker, 3 
Lambda DNA was completely digested with EcoRI and HindIII, then phenol 
extraction and ethanol precipitation were performed by dissolving in storage buffer 
which consists of 10 mM Tris-HCl (pH 7.6) and 1 mM EDTA to form Lambda 
DNA/EcoRI+HindIII Marker 3, in a concentration of 0.5 mg DNA/ml (Figure 2.1). 
                                                 
Figure 2.1. DNA EcoRI and HindIII digested marker-3, 1.0% agarose, 0.5µg/lane, 8 cm 
length gel, 1X TAE, 17V/cm [73]. 
This DNA Marker yields the following 13 discrete fragments (in base pairs): 21226, 
5148, 4973, 4268, 3530, 2027, 1904, 1584, 1375, 947, 831, 564, 125. The cohesive 
ends of the 12 nt cos site of bacteriophage lambda from fragments 21226 bp and 
3530 bp may anneal and form an additional band at 24756 bp [73]. 
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2.1.4. Oligonucleotides  
Synthetic oligonucleotides for desired mutants were designed as follow. Two 
overlapping primers namely; the forward (mutagenic) primer contains a two base 
substitution that introduces the desired amino acid and the reverse primer contains a 
15- nucleotide sequence that is complementary to the forward primer and includes 12 
additional nucleotides at its 3` end were synthesized using an Applied Biosystems 
308A DNA synthesizer by IONTEK. These primers can be seen in Table 2.1. 
Table 2.1. Synthesized synthetic oligonucleotides as used primers in mutagenesis reactions. 
Primer Name Nucleotide Sequence 
GTSD152P1A-F 5’ TCTCACTCTGCTTGTGCTACTTCGACTGG 3’ 
GTSD152P1A-R    5’ ACAAGCAGAGTGAGAATAGAAAGGTACCAC 3’ 
GTSD152T2A-F 5’ CACTCTGCTTGTCCTGCTTCGACTGGTCAG 3’ 
GTSD152T2A-R 5’ AGGACAAGCAGAGTGAGAATAGAAAGGTAC 3’ 
GTSD152S3A-F 5’ TCTGCTTGTCCTACTGCTACTGGTCAGGCGTGC 3’ 
GTSD152S3A-R 5’AGTAGGACAAGCAGAGTGAGAATAGAAAGGTAC 3’ 
GTSD152T4A-F 5’ TGCTTGTCCTACTTCGGCTGGTCAGGCGTG 3’ 
GTSD152T4A-R 5’ CGAAGTAGGACAAGCAGAGTGAGAATAGAA 3’ 
GTSD152G5A-F 5’ TTGTCCTACTTCGACTGCTCAGGCGTGCGGTG 3’ 
GTSD152G5A-R 5’ CAGTCGAAGTAGGACAAGCAGAGTGAGAATAG 3’ 
GTSD152Q6A-F 5’ TTGTCCTACTTCGACTGGTGCTGCGTGCGGTG 3’ 
GTSD152Q6A-R 5’ ACCAGTCGAAGTAGGACAAGCAGAGTGAGAA 3’ 
GTSD152S3AT2A-F 5’ TCACTCTGCTTGTCCTGCTGCTACTGGTCAG 3’ 
GTSD152S3AT2A-R 5’ AGGACAAGCAGAGTGAGAATAGAAAGGTACC 3’ 
GTSD188G5T-F 5’ TTGTTCGCCGCATCCTACGCCGTATTGCGGTGGA 3’ 
GTSD188G5T-R 5’ AGGATGCGGCGAACAAGCAGAGTGAGAATAGAA 3’ 
M13 -96 Primer 5’ CCCTCATAGTTAGCGTAACG 3’ 
2.1.5. Bacterial culture media 
2.1.5.1. Luria Bertani (LB) medium 
10 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 5 g NaCl (Riedel-de-Haen) 
were dissolved in distilled water and completed up to 1 lt and the pH was adjusted to 
7.0-7.5 with 10 M NaOH and sterilized for 15 minutes under 1.5 atm at 121 ˚C. The 
medium was stored at room temperature. 
2.1.5.2. LB agar medium 
10 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 5g NaCl (Riedel-de-Haen), 
15 g bactoagar (Acumedia) were dissolved in distilled water and completed up to 1lt 
and the pH was adjusted to 7.0-7.5 with 10 M NaOH and sterilized for 15 minutes 
under 1.5 atm at 121 ˚C. Following autoclaving, tetracycline solution (Sigma) (final 
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concentration of 10 μg/ml) and X-gal/IPTG solution (final concentration of 40 
μg/ml) (Fermentas/Sigma) were added when the temperature of the medium was 
cooled down to 45-50 ºC. The medium was shaken properly and poured into the 
plates by avoiding any bubble formation (3.5 ml for small plates and 15 ml for big 
plates). After the medium was solidified in the plates, they were turned upside down 
and stored at 4 ˚C for later use. 
2.1.5.3. Top-agar medium 
10 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 5 g NaCl (Riedel-de-Haen), 
1 g MgCl2.6H2O (Riedel-de-Haen), 8 g bactoagar (Acumedia) were dissolved in 
distilled water and completed up to 1 lt and sterilized for 15 minutes under 1.5 atm at 
121 ˚C. The medium was stored at room temperature and in the case of necessity, 
was melted with a heating source to pour onto the LB agar plates.  
2.1.5.4. SOC medium  
20 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 0.5 g NaCl (Riedel-de-
Haen) were dissolved in 950 ml deionized water. 10 ml of 250 mM KCl was added 
and pH was adjusted to 7.0 with NaOH. Mixture was completed to 1 lt with distilled 
water and sterilized for 15 minutes under 1.5 atm at 121 ˚C. The medium was stored 
at room temperature. Just before use, after melting and cooling, 10mM of MgCl2 and 
20mM of glucose were added.  
2.1.5.5. E. coli overnight culture 
5 ml LB solution containing 1 mM MgCl2 and tetracycline, was inoculated with E. 
coli ER2738 glycerol stock. The culture was left in the shaker overnight at 37 °C, 
200 rpm.  
2.1.6. Stock solutions 
2.1.6.1. Tetracycline stock 
20 mg/ml tetracycline (Sigma) was dissolved in 95 % ethanol (Sigma). It was then 
stored at -20 °C at dark to protect from the light due to tetracycline is light-sensitive.      
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2.1.6.2. Xgal/ IPTG stock 
1.25 g IPTG (isopropyl β-D-thiogalactoside) (Sigma) and 1 g Xgal (5-Bromo-4-
chloro-3 indolyl-β-D-galactoside) (Fermentas) were dissolved in 25 ml DMF 
(Dimethyl formamide) (Riedel-de-Haen). Solution was stored at –20°C at dark to 
protect from the light. 
2.1.6.3. Detergent stock  
20 % (w/v) Tween 20 (Riedel-de-Haen) and 20 % (w/v) Tween 80 (Merck) were 
mixed and distilled water was added up to 20 ml.  
2.1.6.4. Glycerol stock solution   
80 ml of 100 % glycerol (Riedel-de-Haen) was mixed with distilled water up to 100 
ml total volume to have 80 % (w/v) glycerol solution. It was sterilized for 15 minutes 
under 1.5 atm at 121˚C and then stored at room temperature.  
2.1.6.5. MgCl2 stock solution 
5 mM  MgCl2.6H2O (Riedel-de-Haen) was dissolved in distilled water up to 100 ml. 
and sterilized with 0.2 μm single use syringe filter.         
2.1.7. Buffer solutions 
2.1.7.1. PEG/NaCl 
20 % (w/v) PEG 8000 (polyethylene glycol-8000) (Sigma), 2.5 M NaCl (Sigma) 
were dissolved in distilled water up to 100ml and sterilized for 15 minutes under 1.5 
atm at 121 ˚C. The solution was stored at room temperature.  
2.1.7.2. PC (Potassium phosphate-Sodium carbonate) suffers 
• PC (no detergent): 55 mM KH2PO4 (Merck), 45 mM Na2CO3 (Merck),    
200 mM NaCl (Sigma) were dissolved in distilled water up to 500 ml and the 
solution was sterilized by using 0.2 μm single use syringe filter. The pH value was 
adjusted to 7.2-7.5.                       
• PC (containing 0.02% detergent): 55 mM KH2PO4 (Merck), 45 mM 
Na2CO3 (Merck), 200 mM NaCl (Sigma), 0.5 ml detergent stock solution were 
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dissolved in distilled water up to 500 ml and the solution was sterilized by using 0.2 
μm single use syringe filter. The pH value was adjusted to 7.2-7.5.   
• PC (containing 0.1% detergent): 55 mM KH2PO4 (Merck), 45 mM Na2CO3 
(Merck), 200 mM NaCl (Sigma), 2.5 ml detergent stock solution were dissolved in 
distilled water up to 500 ml. and the solution was sterilized by using 0.2 μm single 
use syringe filter. The pH value was adjusted to 7.2-7.5.   
• PC (containing 0.5% detergent): 55 mM KH2PO4 (Merck), 45 mM Na2CO3 
(Merck), 200 mM NaCl (Sigma), 12.5 ml detergent stock solution were dissolved in 
distilled water up to 500 ml. and the solution was sterilized by using 0.2 μm single 
use syringe filter. The pH value was adjusted to 7.2-7.5.  
Note: PC buffers can not be sterilized by autoclaving because carbonate ions convert 
to C02 due to high pressure in the autoclave. This causes an increasing of pH up to 
10. 
2.1.7.3. Na-Ac buffer 
3M Na-Ac (Riedel-de-Haen) was dissolved in 65 ml distilled water. pH was adjusted 
to 4.6 and distilled water added up to 100 ml. 
2.1.7.4. TBE (Tris / Borate / EDTA) solution 
10X TBE buffer was prepared by dissolving 108 g Tris-base (Merck), 55 g boric acid 
(Riedel-de-Haen.) and 4 % (v/v) 0.5M EDTA (Merck) pH 8.0. Distilled water was 
added to complete up to 1 l. 
2.1.7.5. TE buffer  
100 µl 1M Tris-HCl, 100 µl 100mM EDTA (Merck) and 1 ml 1M NaCl (Sigma) 
were mixed in 10 ml of distilled and sterilized for 15 minutes under 1.5 atm at 121 
°C.  
2.1.8. Lab equipment  
Lab equipments are given in Appendix B.  
 
 
 24
2.2. Methods 
2.2.1. M13 double-stranded DNA purification 
M13 filamentous bacteriophage has an extraordinary morphology. The infecting 
single-stranded DNA is converted by host enzymes into a double-stranded circular 
form, called replicative form (RF) DNA after infection. Double stranded DNA 
(dsDNA) of newly constructed phages can be purified to use as a template for 
construction of the mutant phages. As RF DNA behaves like a plasmid in the host 
cell, plasmid purification methods can be used for obtaining RF DNA. 
• Phage amplification  
5 µl phage sample from glycerol stock were amplified in 5 ml mid-log E. coli 
ER2738 host cell (12.5 μl E.coli ER2738 host cell overnight culture was inoculated 
into 5 ml LB containing 10 μl MgCl2 and 5 μl tetracycline. The culture was 
incubated at 37 ºC, 225 rpm until mid-log phase (OD600 ~ 0.5) that is known as the 
best phage-host strain propagation period. The incubation period is nearly 4.5 hours. 
E. coli ER2738 host strain contains a mini-transposon, which confers tetracycline 
resistance. Besides, this strain has a rapid growth rate. Due to these acceptable 
properties, this strain is particularly well-suited for M13 propagation.). Amplified 
culture was centrifuged at 5000 rpm for 15 minutes at room temperature to settle 
down bacterial cell. Supernatant containing M13 bacteriophage was transferred to a 
fresh reaction tube.  
• Plasmid purification 
Plasmid DNA was purified from amplified culture by using QIAGEN Plasmid Mini 
Kit Procedure is described in detail below [74].  
1. The bacterial pellet was resuspended completely in 300 µl Buffer P1.  
2. 300 µl Buffer P2 was added. Suspension was mixed gently by inverting the 
tube 5 times and incubated at room temperature for 5 minutes.  
3. 300 µl of chilled Buffer P3 was added. Mixture was mixed immediately but 
gently by inverting the tube 4-6 times and incubated on ice for 5 minutes.  
4. After incubation on ice, mixture was centrifuged in a microcentrifuge for 10  
            minutes at 14000 rpm. Supernatant was saved for further use.  
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5. QIAGEN-tip 20 colon was equilibrated by applying 1 ml of Buffer QBT and 
the column was allowed to empty by gravity flow.  
6. The supernatant obtained and saved in the step 5 was applied to the 
QIAGEN-tip 20 column and it was allowed to enter the resin by gravity flow.  
7. QIAGEN-tip 20 was washed with 1 ml of Buffer QC for 4 times.  
8. The DNA that was bound to the column matrix was then eluted with 800 µl 
of Buffer QF to a 1.5 ml microfuge tube by gravity flow.  
9. Eluted DNA was precipitated with 560µl room temperature isopropanol. It 
was then centrifuged at 10.000 rpm for 30 minutes and the supernatant was 
decanted.  
10. The DNA pellet was washed with 1 ml room temperature 70% ethanol and 
centrifuged for 30 minutes at 10000 rpm. Supernatant was decanted and the 
pellet was allowed to dry at room temperature.  
11. DNA pellet was redissolved in 30 μl elution buffer EB and stored at –20 ºC. 
2.2.1.1. Measurement of DNA concentration 
Each 2 or 4 µl DNA sample was diluted with 998 or 996 µl dH2O (1:500, 1:250). 
The samples were put into the quartz cuvette. The absorbance of DNA was measured 
at 260 nm and at 280 nm to quantify the amount of DNA. The purity of DNA 
samples was determined by calculating the ratio of absorbent at 260/280 nm. 
 2.2.2. Site directed mutagenesis  
Alanine scanning and Glycine-Threonine substitution reactions were achieved via 
site-directed mutagenesis approach. GeneTailor Site-Directed Mutagenesis Kit was 
used for phage DNA manipulations [70]. In general, this mutagenesis system mainly 
includes three steps; DNA methylation, mutagenesis PCR and transformation. At 
following subsections protocol is discussed in detail. 
2.2.2.1. DNA methylation  
For the methylation of the template DNA, DNA cytosine methylase encoded by the 
dcm gene of E.coli was used. This enzyme modifies the internal cytosine residue at 
the C5- position on both strands within the sequence 5'...CC(A/T)GG-3'. As 
 26
methylated DNA was transferred into E. coli DH5αTM-T1R host strain, it was splited 
with the Mcr and Mrr restriction systems of the host. This system provides the 
separation of mutated PCR product from unmutated template during amplification 
period following transformation [69, 70]. 
Methylation reaction  
dsDNA   1 µl (100 ng)  
Methylation Buffer  1.6 µl  
10X SAM   1.6 µl  
DNA Methylase  1 µl (4U/µl)  
dH2O    10.8 µl  
Total volume   16 µl  
Reaction conditions 
Incubated at 37 °C for 1 hour.  
2.2.2.2. Mutagenesis PCR  
For each mutagenesis reactions, two overlapping primers, one of which containing 
desired mutation were designed. For every mutation process, methylated replicative 
form of the template phage DNA was used. In one alanine mutagenesis reaction, 
template DNA was the mutated phage DNA to get a double alanine mutation. 
Mutagenesis reactions are described detail below.  
Mutagenesis reactions  
10X High Fidelity PCR Buffer    5 µl  
10 mM dNTP       1.5 µl  
50 mM MgSO4      1 µl  
Forward Primer (10 μM)     1.5 µl  
Reverse Primer (10 μM)     1.5 µl  
Methylated DNA      5 µl  
Platinum® Taq DNA Polymerase High Fidelity 0.5 µl  
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dH2O        34 µl  
Total Volume      50 µl  
Reaction conditions  
94 ºC 2 minutes  
94 ºC 30 seconds  
55 ºC 30 seconds         20 cycles  
68 ºC 7.5 minutes  
68 ºC 10 minutes  
2.2.2.3. Transformation  
1. 50 μl vial of One Shot® MAX Efficiency® DH5α™-T1R competent cells from 
– 80 ºC stock were taken and thaw on ice approximately 5-7 minutes.  
2. 2-5 μl of mutagenesis reaction was added directly into vial of cell and mixed 
by tapping gently.  
3. Tube was incubated on ice for 30 minutes.  
4. To perform the heat shock, the tube was incubated in the 42 ºC water bath for 
exactly 30 seconds without mixing or shaking.  
5. Vials were removed from the 42 ºC water bath and covered with ice for 1 
minute.  
6. 500 µl of pre-warmed SOC medium was added to the vial and then incubated 
at 37 ºC for exactly 30 minutes at 250 rpm in a shaking incubator.  
7. 50-100-150 and 200 μl transformation reactions were put each of 5 ml top 
agar aliquots including 25 μl 5 mM MgCl2 and 180 μl E. coli DH5αTM-FT 
mid-log culture, mixed by vortexing and poured onto LB plates containing 
Xgal/IPTG-Tet according to the dilution rates (50-100-150-200 μl).  
8. After the plates have solidified, they have been inverted and incubated at 37 
ºC overnight.  
Next day, blue plaques seen on the LB plate were put into the storage Elisa plates. 
These phages were amplified and ssDNA (single-stranded) and dsDNA (double-
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stranded) of newly constructed phages were purified to use as a template for 
sequence analysis and following mutagenesis reaction respectively. 
2.2.3. Saving phage clones  
• Preparation of storage stock of phages  
1. 200 μl PC buffer containing 0.02 % detergent solution was put into each well 
of a sterile 96-well Elisa plate. 
2. Elisa plate containing phage clones was placed into the incubator at 60 ºC for 
45 min. After incubation, plate was cooled in laminar flow and left at 4 ºC for 
overnight.  
• Preparation of glycerol stock of phage  
1. 60 μl sterilized 80% glycerol solution was put into each well of a fresh 96-
well plate.  
2. 50 μl clone from the storage plate was added into the glycerol containing 
plates. 
3. Plates were covered by parafilm and placed into – 80 ºC. 
2.2.4. M13 single-stranded DNA purification 
For the sequencing of the individual plaques, ssDNAs of the picked plaques were 
needed to be isolated. QIAprep® Spin M13 Kit was used for the isolation of ssDNAs. 
The procedure is given schematically in Figure 2.2 and written below [75]. 
1. 50 μl from each individual sample which belongs to only one phage plaque 
was taken from the glycerol stock and added into 5 ml E. coli ER2738 host 
culture which had been incubated until mid-log phase (OD 600 ~0.5). Phage 
and bacteria mixture was incubated for 4.5 hours for E. coli ER2738 infection 
by phage and amplification.  
2. Culture containing tubes were centrifuged at 5000 rpm for 15 minutes at 
room temperature. Supernatant containing M13 bacteriophage was 
transferred into a fresh reaction tube. During transferring the supernatant, 
bacterial pellet was not disturbed due to any carryover of bacterial cells will 
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result in contamination of the M13 precipitation with bacterial chromosomal 
DNA or double-stranded bacteriophage RF DNA. 
 
Figure 2.2. M13 ssDNA isolation procedure [75]. 
3. Buffer MP was added 1/100 volume (i.e.10μl per 1 ml of phage supernatant) 
onto the supernatant in the reaction tube. It was mixed by vortexing and 
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incubated at room temperature for at least 2 minutes. During this step, 
bacteriophage particles were precipitated from the culture medium. 
4. A QIAprep spin column was placed in a 2 ml microcentrifuge tube and 0.7 ml 
of the sample was applied to the QIAprep spin column. 
5. Reaction tube was centrifuged for 15 seconds at 8000 rpm and discarded 
flow-through from collection tube. Here, intact bacteriophage was retained on 
the QIAprep silica-gel membrane.  
6. The last step was repeated until all supernatant passed through QIAprep spin 
column. 
7. 0.7 ml MLB buffer was added for M13 lysis and binding, to the QIAprep spin 
column and centrifuged for 15 seconds at 8000 rpm. This step creates 
appropriate conditions for binding of the M13 DNA to the QIAprep silica-gel 
membrane. Bacteriophage lysis begins. 
8. Another 0.7 ml MLB buffer was added into the QIAprep spin column and 
incubated for 1 minute at room temperature to lyse the bacteriophage 
completely. QIAprep spin column was centrifuged for 15 seconds at 8000 
rpm. M13 single-stranded DNA is released from bacteriophage particles and 
adsorbed to the QIAprep to the silica gel membrane. 
9. 0.7 ml Buffer PE was added into the QIAprep column and centrifuged for 15 
seconds at 8000 rpm to remove the residual salt. 
10. Buffer PE was discarded from collection tube and QIAprep spin column was 
centrifuged for 15 seconds at 8000 rpm to remove residual buffer PE. It is 
important not to dry the QIAprep membrane quick microcentrifugation step. 
This prevents residual ethanol from being carried over into subsequent 
reactions. QIAprep spin column was placed in a clean 1.5 ml microcentrifuge 
tube. 100 μl EB buffer (10 mM tris.Cl, pH 8.5) was added onto the center of 
the column membrane to elute the DNA. Incubation of elution buffer in the 
QIAprep spin column significantly increases the recovery of single-stranded 
M13 DNA molecules, which adsorb tightly to the silica membrane. 
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11. After 10 minutes of waiting at room temperature, the tube is centrifuged for 
30 seconds at 8000 rpm to collect the isolated ssDNA samples in the QIAprep 
spin column. 
2.2.5. Sequencing of DNA sample 
2.2.5.1. PCR conditions for single-stranded DNA sequencing 
PCR reactions were done for the total volume of 10 µl in the 0.2 ml PCR reaction 
tubes. 
Big dye reaction mix*  2 µl  
5X sequencing buffer   1 µl  
Template ssDNA   1 µl (50 ng)  
M13 –96 Primer   3.2 µl  
dH2O     2.8 µl  
Total volume    10 µl  
*Big dye ® Terminator v3.1 cycle sequencing Kit from Applied Biosystems for the 
amplification of ssDNAs.  
Reaction conditions  
95oC  4 minutes  
95oC  30 seconds  
55oC  30 seconds       35 cycles  
60oC  4 minutes  
2.2.5.2. Purification of PCR products  
1. 2 µl (3M pH 4.6 sodium acetate) and 50 µl 95 % ethanol were mixed for each 
sample. 
2. 52 µl mixture was put into each PCR product and all samples were put in dry 
ice for 30 minutes. 
3. All samples were centrifuged for 30 minutes at 14000 rpm. 
4. Supernatant was discarded from each sample and 250 µl cold ethanol was put 
into each sample. 
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5. All samples were centrifuged for 30 minutes at 14000 rpm. 
6. Ethanol was discarded from each sample and 20 µl hi-di formamide was put 
into each sample. 
7. Samples were put first 95 ºC and then – 20 ºC for 5 minutes to denaturate the 
samples. 
DNA samples were sequenced by using an ABI 3100 Avant (PE, Applied Biosystem, 
CA) automated sequencer. 
2.2.6. Phage amplification and purification  
1. At the end of 4.5 hours of growth period, E. coli - phage culture (in 50 ml 
LB) was transferred into 250 ml sterilized centrifuge tubes.  
2. Samples were centrifuged at 8000 rpm for 10 minutes. 
3. Supernatants were transferred into 250 ml sterilized centrifuge tubes. 
4. 8.33 ml (1:6) of PEG / NaCl solution was added into supernatant to 
precipitate phage and it was left for overnight at 4 0C. 
5. After overnight, samples were centrifuged at 8000 rpm for 10 minutes. 
6. Supernatants were discarded and phage pellet was resuspended with 5 ml PC   
buffer (no detergent) by shaking to remove any remaining E. coli. 
7. Samples were centrifuged at 8000 rpm for 10 minutes. 
8. Supernatant was transferred into 50 ml sterilized centrifuge tubes. 
9. 0.833 ml of PEG / NaCl (1:6) was added into the solution to precipitate phage 
and the solution was left for 2 hours at 4 0C. 
10. Samples were centrifuged at 10000 rpm for 10 minutes. 
11. Supernatants were discarded and phage pellets were resuspended by pipetting 
or shaking with 1 ml PC buffer (no detergent) to remove E-coli. 
12. Samples were centrifuged at 10000 rpm for 10 minutes and supernatants were 
transferred into sterilized microfuge tubes. 
 33
13. 0.166 ml of PEG / NaCl solution (1:6) was added into the microfuge tube to 
precipitate phage, sample was vortexed for 5 seconds, and left for 10 minutes 
at room temperature. 
14. Samples were centrifuged at 13500 rpm for 1.5 minutes to get the compact 
phage. 
15. Supernatant was discarded and phage pellet was resuspended with 0.2 ml PC 
buffer (no detergent) by pipetting gently. 
16. Samples were centrifuged at 13500 rpm for 1.5 minutes. 
17. Supernatant were transferred into sterilized microfuge tubes and stored at 4 
0C. 
At the end of the purification step, blue-white screening experiment was done.  
2.2.7. Titers of the selected phages 
2.2.7.1. Blue-white screening experiment 
Blue-white screening experiment is carried out to determine the phage titers. 
Basically, amplified phages are grown in the plates which have Xgal / IPTG and 
tetracycline. 50 μl Xgal/IPTG from 20 mg/ml stock, 100 μl 1M MgCl2 (1:500), 50 μl 
tetracycline (1:1000) were put into 50 ml liquid warm LB agar in 100 ml glass 
medium flask and it was poured into plastic sterile Petri dishes.  
2.2.7.2. Preparation of diluted phage and plating 
90 μl PC buffer (no detergent) was put into the first well in Elisa plate. 180 μl PC 
buffer (no detergent) was put into other wells to dilute the sample. 10 μl phage stock 
solution was put in the first well having 10-1 dilution. Phage and PC buffer were 
mixed by pipetting. 20 μl sample was taken from the first well and put into the 
second well to have totally 200 μl of solution mix having 10-2 dilution level of the 
phages. The remaining serial dilutions were done the same way as it is labeled in 
Figure 2.3.  
One night before plating, overnight culture was prepared to be used in the day of the 
plating. 5 ml LB solution containing 10 μl 1M MgCI2 (1:500), 5 μl tetracycline 
(1:1000) was incubated with 12.5 μl E. coli ER2738 from overnight culture in 50 ml 
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falcon tube. It was incubated until mid- log phase (OD600 ~ 0.5) at 37 ºC and 200 
rpm. 
Xgal/IPTG-tet plates are taken out from 4 oC refrigerator and put at room 
temperature and labeled. Previously melted top agar is placed in the water bath at ~ 
50 oC to prevent solidification of the top agar till adding the diluted phage solutions.  
 
Figure 2.3. Making the serial dilutions on the Elisa plate. 
20 μl diluted phage solution is mixed with 180 μl LB solution containing E. coli cells 
with OD600 ~ 0.5 resulting one more dilution of the phages. The resulting solution 
was mixed with warm LB agar (0.5 ml for small Petri dishes and 3.5 ml for big Petri 
dishes) in 15 ml falcon tubes and vortexed. The phage and bacteria mixture solution 
was poured onto the plates and waited for 5-10 minutes for the solidification of the 
top agar. All Petri dishes were inverted and incubated at 37 oC for 8-14 hours. 
2.2.8. Characterization of phage display peptides  
Binding affinity and specificity of mutant phages were compared with the wild type 
phage through immunolabelling fluorescent microscopy and ELISA analysis. At the 
beginning of the characterization experiments, platinum or palladium powder was 
cleaned following the steps described below.  
2.2.8.1. Cleaning of platinum and palladium powder  
1. Around 100 mg of platinum or palladium powder was weighed and put into 
pre-weighed 1.5 ml microfuge tube. 
2. 100 μl dH2O and 900 μl CH3OH/acetone (1:1) mixture were added into the 
tube. The powder was dissolved gently by pipetting. 
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3. The sample was vortexed for 5-10 minutes to observe the forming clumps 
and then sonicated for 20 minutes in an ultrasonic bath to break the clumps. 
4. The powder was vortexed quickly to resuspend and centrifuged at 200 g for 
1.5 minutes. 
5. The supernatant was removed and 1 ml 50 % isopropanol was added onto the 
powder. 
6. Powder was vortexed for 5-10 minutes and then sonicated for 20 minutes in 
the ultrasonic bath. 
7. The powder was vortexed quickly to resuspend and spinned down at 200 g 
for 3 minutes. 
8. The supernatant was removed and 1 ml 0.5 % PC buffer was added onto the 
powder. 
9. The powder was first vortexed for 5-10 minutes and then sonicated for 60 
minutes. 
10. The powder was vortexed quickly to resuspend. 
11. The powder was centrifuged at 200 g for 1.5 minutes. 
12. The supernatant was removed and 1ml 0.5 % PC buffer was added onto the 
powder. 
13. 100 μl of powder solution was transferred into each sterile microfuge tube. 
14. Powder was spinned down at 200 g for 1.5 minutes. 
15. Powder was first washed twice with dH2O and then with isopropanol. 
16. Samples were dried under the vacuum. 
17. All samples were weighed to determine the amount of powder into the each 
tube. 
2.2.8.2. Fluorescence microscopy experiment procedure  
The binding of the phage samples on the platinum or palladium particles can be 
observed visually under the fluorescence microscopy indirectly. Zenon complex 
which has labeled Fab fragment bound on IgG is used to label the phages for indirect 
observation. The procedure is written below: 
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1. A proper amount of previously cleaned platinum or palladium powder is 
incubated with 5 μl phage (1011 PFU/10µl) in PC buffer containing 0.1 % 
detergent and rotated overnight on a running cyclinder to provide binding.  
2. Each phage sample is labeled according to the immunolabelling procedure as 
in Figure 2.4. First, Anti-M13 pIII monoclonal antibody (Amersham 
Biosciences) which is specific to M13 gp8 protein and Alexa-Fluor 
conjugated secondary antibody fragments (Zenon Alexa, Molecular Probes 
Inc.) that contains fluorescence dye were incubated (1: 5 ratio) for 30 minutes 
in a microfuge tube covered by aluminum folio to protect from the light.  
 
Figure 2.4. Immunolabelling procedure for fluorescence microscopy. 
3. While Zenon mixture is being prepared, overnight phage-platinum or 
palladium powder solution is centrifuged at 1000 rpm for 1.5 minutes. The 
supernatant is discarded and 0.1 % PC buffer is added on the sample for 15 
minutes rotation on running cylinder to wash unbound phage out of the 
solution.  
4. The solution is centrifuged again at 1000 rpm for 1.5 minutes and the 
supernatant is discarded.  
5. 3 μl Zenon dye complex and 497 μl PC buffer containing no detergent were 
put on the phage–platinum or palladium solution and incubated for 30 
minutes on running cylinder to let phage- mixture interaction. The tube is 
protected from light by covering.  
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6. The solution is centrifuged again at 1000 rpm for 1.5 minutes and the 
supernatant is discarded. 
7. 0.5 ml 0.1 % PC buffer is added into the tube and the powder is washed 3 
times by pipetting. 
8. The mixture solution is centrifuged again at 1000 rpm for 1.5 minutes and the 
supernatant is discarded. 
9. Another 0.5 ml 0.1 % PC buffer is added into the tube and the powder is 
washed 3 times by pipetting. 
10. The mixture solution is centrifuged again at 1000 rpm for 1.5 minutes and the 
supernatant is discarded. 
11. 30 μl 0 % PC buffer is added onto the powder solution and visualized by 
fluorescence microscopy (BX 60, Olympus Corporation) at 20X 
magnification under WIB filter.   
2.2.8.3. Enzyme-Linked Immuno Sorbent Assay (ELISA) analysis procedure  
1. Proper amount of clean platinum or palladium powder incubated with 10µl 
phage (1011 PFU/10µl) in 190µl PC buffer containing 2 % BSA for 2 hours 
on a running cylinder to provide binding.  
2. After incubation period, phage-powder mix was washed 3 times with 200µl 
buffer containing 0.05 % detergent.  
3. 200µl PC buffer containing 2 % BSA was added on washed phage-powder 
mix and incubated with 0.4 µl HRP-AntiM13 antibody for 30 minutes by 
rotating as shown in Figure 2.5.  
 
Figure 2.5. ELISA procedure [76]. 
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4. After incubation period, 4 times washing step was performed to send away 
unbound antibody from solution and than phage-powder-antibody conjugate 
suspended in 200µl PC buffer containing 0.05 % detergent.  
5. Enzymatic reaction was started when 100µl TMP (Pierce) was added into 
solution.  
6. Reaction was ended when the color of the solution turned to blue with 100µl 
1M H2SO4. Colorful supernatant was measured at 450nm.  
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3. RESULTS AND DISCUSSION 
Binding events are complex and takes an important role in biomolecular recognition. 
Though the mechanism of binding of a polypeptide to the surface of an inorganic 
material has not been understood yet, identification of many short polypeptide 
sequences specific to metals like gold (Au), silver (Ag) and platinum (Pt) is growing 
field by many groups [12]. Already, these polypeptides are shown to have many 
effects to be potential building blocks for future engineering materials. 
It can be clearly seen that the structure and function of a polypeptide is strongly 
linked with its amino acid sequence. Therefore, if the binding mechanism of a 
biomolecule - in this case polypeptide or protein – is desired to be lightened, 
investigation of amino acid sequence gains importance. When we look at the 
identified sequences for Pt via phage display, we face with much more smaller 
sequences (7 amino acids) than the ones defined for Au (14 amino acids) and Ag (12 
amino acids) by cell surface display and phage display. Au and Ag binding peptides 
have similar amino acid properties: They have conserved hydrophobicity and 
polarity with hydroxyl containing amino acids [66].  
This analogy also can be seen in the Pt and palladium (Pd) binding sequences. It was 
observed that most Pt binding sequences consist of serine (Ser) and threonine (Thr) 
repeating amino acids. These two amino acids have hydroxyl groups which make 
them more reactive. Therefore, it can be thought that hydroxyl groups in Ser and Thr 
seemed to play an important role for binding to the inorganic material, especially to 
platinum [31, 67]. 
In this study we have investigated the core amino acids that might be responsible for 
binding to Pt. To reach this aim, we have used one of the strong, 7- mer Pt binder, 
SD152, PTSTGQA. This peptide was previously identified from a random peptide 
phage display disulphide constrained library [12, 31, 66, 67]. We have applied site 
directed mutagenesis reactions to substitute the amino acid sequence one by one with 
alanine amino acid (Ala) thus Ala change is generally used for the investigation of 
side chains.  
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Next, based on the knowledge that we gained from platinum binder, we have used 
another phage clone displaying 7-mer peptide which was characterized as a weak 
binder for Pd, SD188, SPHPGPY. We have utilized site directed mutagenesis 
procedure this time to enhance the binding event by replacing glycine amino acid 
(Gly) to threonine (Thr).  
Binding properties of these mutants have been assessed by Fluorescence Microscopy 
(FM) and Enzyme-Linked Immuno Sorbent Assay (ELISA) to compare with the 
unmutated, wild type SD152 and SD188. 
3.1. Obtaining Double-Stranded DNA (dsDNA) of Pt and Pd Binding Sequences 
Site directed mutagenesis procedure requires dsDNA of the binding sequences. To 
obtain these DNAs, M13 dsDNA purification has been applied. Firstly, SD152 and 
SD188 containing M13 phages were amplified. Thus, M13 dsDNA behaves like a 
plasmid (replicative form) when it is in the host cell, plasmid purification methods 
can be used for obtaining M13 dsDNA. So, QIAGEN Plasmid Mini Kit is used for 
obtaining dsDNAs. The performance of the dsDNA obtain was analyzed by agarose 
gel electrophoresis (Figure 3.1)  
 
Figure 3.1. 1% agarose gel. M3: Lambda DNA/EcoRI+HindIII Marker, 3. C: Control 
reaction with no DNA. SD152 dsDNAs after plasmid purification method. 
3.2. Site Directed Mutagenesis Reactions for Pt and Pd Binding Sequences 
Site directed mutagenesis reactions mainly consist of three steps and all these steps 
were applied to both SD152 and SD188 peptides to obtain desirable mutants. These 
steps are: 
a) Methylation of the template dsDNA. 
b) Site directed mutagenesis with PCR and overlapping primers. 
M3 C SD152 dsDNAs  
21226 bp 
5148 bp 
7294 bp
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c) Transformation. 
Replicative form (dsDNA) of phage genome containing SD152 and SD188 were 
methylated by DNA methylase. These methylated dsDNAs will be used as a template 
in PCR. 
For SD152, two overlapping primers namely; the forward primer contains the desired 
Ala mutation and the reverse primer that is complementary to the forward primer 
were designed and used in site directed mutagenesis with PCR. The same concept 
was used for the design of SD188 primers. But this time, forward primer carries the 
Thr mutation. Table 3.1 shows these constructed oligonucleotides that were used as 
primers in PCR. 
Table 3.1. Primers that were used in mutagenesis PCR. 
Primer Name        Nucleotide Sequence 
GTSD152P1A-F        5’ TCTCACTCTGCTTGTGCTACTTCGACTGG 3’ 
GTSD152P1A-R           5’ ACAAGCAGAGTGAGAATAGAAAGGTACCAC 3’ 
GTSD152T2A-F        5’ CACTCTGCTTGTCCTGCTTCGACTGGTCAG 3’ 
GTSD152T2A-R        5’ AGGACAAGCAGAGTGAGAATAGAAAGGTAC 3’ 
GTSD152S3A-F        5’ TCTGCTTGTCCTACTGCTACTGGTCAGGCGTGC 3’ 
GTSD152S3A-R        5’AGTAGGACAAGCAGAGTGAGAATAGAAAGGTAC 3’ 
GTSD152T4A-F        5’ TGCTTGTCCTACTTCGGCTGGTCAGGCGTG 3’ 
GTSD152T4A-R        5’ CGAAGTAGGACAAGCAGAGTGAGAATAGAA 3’ 
GTSD152G5A-F        5’ TTGTCCTACTTCGACTGCTCAGGCGTGCGGTG 3’ 
GTSD152G5A-R        5’ CAGTCGAAGTAGGACAAGCAGAGTGAGAATAG 3’ 
GTSD152Q6A-F        5’ TTGTCCTACTTCGACTGGTGCTGCGTGCGGTG 3’ 
GTSD152Q6A-R        5’ ACCAGTCGAAGTAGGACAAGCAGAGTGAGAA 3’ 
GTSD152S3AT2A-F        5’ TCACTCTGCTTGTCCTGCTGCTACTGGTCAG 3’ 
GTSD152S3AT2A-R        5’ AGGACAAGCAGAGTGAGAATAGAAAGGTACC 3’ 
GTSD188G5T-F        5’ TTGTTCGCCGCATCCTACGCCGTATTGCGGTGGA 3’ 
GTSD188G5T-R        5’ AGGATGCGGCGAACAAGCAGAGTGAGAATAGAA 3’ 
After the PCR, reaction was observed on an agarose gel (Figure 3.2). 
 
 
Figure 3.2. 1% agarose gel. M3: Lambda DNA/EcoRI+HindIII Marker, 3. C: Control 
reaction with no DNA. Mutagenesis reaction represents both SD152 and SD188 mutants. 
M3 Mutagenesis reaction C 
21226 bp  
5148 bp 
7294 bp 
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The enzyme mixture in site directed mutagenesis reactions is also important. This 
mixture includes a proofreading enzyme that increases fidelity comparing to Taq 
DNA polymerase alone and allows amplification of complex and long DNA 
templates up to 20 kb with some optimization. So, PCR for long DNA sequences can 
be done easily with no doubt. 
In the procedure of SD152 double Ala mutation, the primer design idea was the again 
same. But this time, we used an Ala mutant as a template to get a double Ala 
mutation. The forward and reverse primers were again designed with the same 
limitations. 
After observation of desired DNA fragments on agarose gel, transformation of these 
DNA fragments into the bacterial host step were accomplished. In this step, two 
bacterial strains, E. coli DH5α-T1R and E. coli DH5α-FT, were used. Firstly, PCR 
product was transformed into E. coli DH5α-T1R chemically competent cell which 
provides self-ligation of linear PCR product to form the circular phage DNA and 
destruction of methylated template DNA consequently, leaving only the mutated 
phage DNA. Destruction of methylated DNA was performed by an endonuclease 
which is active in E. coli DH5α-T1R host cells. Though this strain helps to get rid of 
the template DNA, it does not contain F pilus. For phage infection, F pilus is a must. 
Then the second bacterial strain, E. coli DH5α-FT, takes role. Assembled phage 
containing the desired mutation was amplified in this second bacterial strain. At the 
end, the transformation reaction was plated onto LB agar plates with mid-log E. coli 
DH5α-FT cell culture to obtain the mutant phages with blue-white screening. 
3.3. Obtaining Single-Stranded DNA (ssDNA) for Sequencing 
After the last step of site directed mutagenesis procedure, transformation into the 
host cell of the mutant dsDNA, blue phage plaques observed on LB plates were 
picked up with a pipette tip and put into PC Buffer containing wells of an ELISA 
plate to get storage plates. Phage solutions in storage plates were inoculated into 
mid-log E. coli DH5α-FT cell culture in liquid media for amplification. Single 
stranded DNA (ssDNA) was purified from amplified phages by using QIAprep® 
Spin M13 Kit and observed on an agarose gel (Figure 3.3). 
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Figure 3.3. 1% agarose gel. M3: Lambda DNA/EcoRI+HindIII Marker, 3. ssDNA obtained 
from phage amplification and ssDNA purification. 
These obtained ssDNAs then were prepared for the DNA sequencing if they were 
correct mutants to check if the desired mutants were obtained correctly. 
 After all of these steps, DNA sequencing analysis confirmed that we had constructed 
all the desired mutant phages. These mutants and the changes in their amino acid 
sequences can be seen on Table 3.2 and Table 3.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
M3 M3 Single stranded phage DNAs  
21226 bp 
   5148 bp 7294 bp
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Table 3.2. The desired mutants for SD152 and the changes in amino acid sequences. 
 
 
                                  PTATGQA SD152S3A 
 
                                   PASTGQA SD152T2A 
 
                                   PTSAGQA SD152T4A 
 
                                  ATSTGQA 
 
SD152P1A 
                                  PTSTGQA SD152 WT 
                                                                 PTSTAQA 
 
SD152G5A 
                                                                  PTSTGAA 
 
SD152Q6A 
 
 
                                                                    PAATGQA SD152T2AS3A 
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Table 3.3. The desired mutant for SD188 and the change in amino acid sequence. 
 
3.4. Characterization of Mutant Peptides 
Following site directed mutagenesis of desired mutants, FM and ELISA analysis of 
mutant peptides were carried out to compare the binding efficiency of the mutants 
with the wild type peptides that were selected by phage display.  
3.4.1. Fluorescent microscopy analysis 
All the mutant phages were purified and mixed with Pt or Pd powder. The mixture 
was rotated overnight and washed with PC buffer to remove any unbound phage 
from the organic surface. After then, anti-M13 g8p monoclonal antibody and Alexa-
Fluor conjugated secondary antibody fragments were added to detect the phage as 
explained in Material and Methods section. The samples were observed under FM 
and the affinity of the mutant sequences was determined. Binding percentages of 
each peptide were determined with FM images obtained from each peptide.  
The binding percentages of the wild type and mutant peptide binders were calculated 
as following logic: First, the ratio of powder area to the total area, (R1), was 
calculated by using the fluorescence microscopy pixel counting software. Then, the 
ratio of binding area to the total area, (R2), was calculated. The (R2/R1) x 100 value 
gave us the percentage coverage (binding) for each measured peptide. 
Figure 3.4 shows the optic and fluorescent microscopy images of constraint SD152 
and its two mutations, SD152P1A and SD152T2A. According to the calculated 
binding percentages from this image, SD152 has a nearly 11% binding affinity to Pt. 
These percentages also are different for mutant phages; for SD152P1A it is 8% and 
for SD152T2A the percentage is decreased to 0.15%. 
                                   SPHPTPY 
 
SD188G5T 
                                   SPHPGPY SD188 WT 
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SD152 wild type (10.45% binding.) 
 SD152P1A mutation (8 % binding) 
 
SD152T2A mutation (0.15 % binding) 
Figure 3.4. Optical and fluorescent microscopy images of SD152, SD152P1A and 
SD152T2A. 
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Figure 3.5 shows the optic and fluorescent microscopy images of mutations, 
SD152S3A and SD152T4A. 
 
SD152S3A mutation (0.1% binding) 
 
SD152T4A mutation (1.45% binding) 
Figure 3.5. Optical and fluorescent microscopy images of SD152S3A and SD152T4A. 
The decrease on binding percentage continues with these two mutant phages. But the 
decrease on SD152S3A is so certain that Ala mutation is said to be so powerful on 
that phage thus the binding affinity is nearly 0. With only this result, the importance 
of Ser can be seen on binding.  
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SD152G5A mutation (4% binding) 
 
SD152Q6A mutation (1.75% binding) 
 
SD152T2AS3A mutation (0,15% binding) 
Figure 3.6. Optical and fluorescent microscopy images of SD152G5A, SD152Q6A and 
SD152T2AS3A. 
In Figure 3.6, the effect of Ala mutation can be clearly seen. Except SD152G5A 
mutant, the mutations force the binding affinity to nearly nonbinding level. We also 
see that the double Ala mutation (PAATGQA) has a drastic effect on SD152. 
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It is observed that the substitution of the target amino acids with Ala resulted with 
valuable indications. These indications show the importance of Thr and Ser on 
binding to Pt. 
The same FM analyses were carried out to characterize the binding affinity of 
SD188G5T (Figure 3.7). 
 
SD188 wild type (1.7% binding) 
 
SD188G5T mutation (2.5% binding) 
Figure 3.7. Optical and fluorescent microscopy images of SD188 wild type and its mutant, 
SD188G5T. 
Repeating Ser and Thr consisted peptides are mostly observed in Pt binding 
sequences. These two amino acids have similar structures containing aliphatic 
hydroxyl groups which make them much more reactive than all other amino acids 
with inert side chains.  
That is why Gly is changed to Thr in SD188. We see a meaningful increase on Pd 
binding in FM images (Figure 3.7). So we can assume that Thr may have the same 
boosting effect on binding to Pd. 
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In the next step, ELISA analyses were performed as an alternative method to 
characterize the affinity property of the constructed mutants and their results were 
compared with FM analysis to verify.  
3.4.2. ELISA analysis 
All the mutant phages were purified and mixed with Pt or Pd powder. The mixture 
was rotated for 2 hours and washed with 0.05 % detergent to remove any unbound 
phage from the organic surface. HRP-AntiM13 antibody conjugate was added to the 
mixture and left for incubation for 30 minutes. Then the mixture was washed several 
times to eliminate the unbound antibody. The substrate of HRP named TMP was 
added to this washed mixture and color change was observed due to the enzymatic 
reaction in the mixture. The color changed yellow to blue. This color change was 
measured at 450nm. 
ELISA analyses were accomplished for SD152 and SD188 mutants. As a standard, 
the phage concentration is held on the same concentration for every mutation. For 
each mutation, a triple experiment set is formed. Wild type M13KE was used in all 
measurements as a control. The results of ELISA experiments performed with 
109/µL of phage particles for Pt and Pd are given in Figure 3.8 and Figure 3.9. 
 
 
Figure 3.8. The graph shows the measured absorbance levels after ELISA analysis of 
PtBP1(SD152wt) and associated mutants.  
Absorbance 
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Figure 3.9. The graph shows the measured absorbance levels after ELISA analysis of SD188 
and its mutant, SD188G5T. 
Our results show that, ELISA analyses verified the results of FM analyses. Binding 
on platinum surface is related with amino acids which has hydroxyl side chains and 
Thr and Ser were the most effective ones. When these amino acids leave the peptide 
sequence with the change of Ala, there is a significant decrease in all mutations for 
Pt binding peptide, SD152. In addition, these amino acids can effect the binding for 
Pd. Experiments show that Thr also triggers the binding event on Pd surfaces. 
 
 
 
 
 
 
 
 
 
 
 
Absorbance 
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4. CONCLUSION 
Site directed mutagenesis reactions for two phage clones displaying selected and well 
characterized platinum and palladium binding peptides, SD152 and SD188, were 
accomplished.  
SD152 and SD188 are 7-mer peptides with the amino acid sequences of PTSTGQA 
and SPHPGPY. SD152 has been characterized as a strong platinum (Pt) binding 
peptide and SD188 has been characterized as a weak palladium (Pd) binding peptide 
via characterization methods such as fluorescence microscopy (FM) when they were 
in disulphide constraint forms. 
Site directed mutagenesis allows one to substitute the amino acids in a specific site of 
protein with another amino acid obtaining different properties. Through this ability, 
comparing the binding affinity of each mutant with originally selected peptide 
provides understanding the effect of mutated amino acid. With this knowledge, one 
can tune up the binding from strong to weak, or from weak to strong. 
To reach this aim, amino acids that were thought to be responsible for binding in 
SD152 changed with alanine amino acid (Ala) one by one. Because substitution with 
Ala removes all side chain atoms past the β-carbon and the effects of single Ala 
substitution can be used to understand the roles of side chains. 
Also a double Ala mutation was performed using a single Ala mutant as a template to 
test the effect of double Ala mutation in peptide function on binding. 
Furthermore, site directed mutagenesis was utilized for weak Pd binder peptide, 
SD188, this time to increase the peptide affinity for the inorganic surface. For 
enhancement for binding, we performed polar group insertion as the result obtained 
from platinum binder showed that polar groups are effective in the binding process.  
The binding affinity of palladium binder, SD188, with threonine substitution (Thr) to 
glycine (Gly) position was enhanced. 
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APPENDIX 
A. Color coding of amino acids 
Table A.1. Color coding of amino acids. 
Hydrophobic  A G V F P M I L W 
Acidic D E 
Basic R K 
Hydroxyl S T Y 
Amine + Basic H C N Q 
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B. Lab Equipments 
Autoclaves    : 2540 ML benchtop autoclave,                                                   
                                      Systec GmbH  Labor-Systemtechnik.  
                                                            : NuveOT 4060 vertical steam sterilizer, Nuve.  
Centrifuges                                        : Avanti J-30I, Beckman Coulter.  
                                                            : Microfuge 18, Beckman Coulter.  
Centrifuge rotors                              : JA30.50Ti, Beckman Coulter.  
                                                            : F241.5P, Beckman Coulter.  
Deep freezes and refrigerators   : Heto Polar Bear 4410 ultra freezer, JOUAN  
  Nordic A/S, catalog #003431.  
: 2021 D deep freezer, Arcelik.  
: 1061 M refrigerator, Arcelik.  
Electrophoresis equipments  : E-C Mini Cell Primo EC320, E-C Apparatus.  
: Mini-PROTEAN 3 Cell and Single-Row  
  AnyGel Stand, Catalog #165-3321, Bio-Rad.  
: Mini-V 8.10 Vertical Gel Electrophoresis  
  System, Life Technologies GibcoBrl (now  
  Invitrogen), Catalog #21078.  
Gel documentation system   : UVIpro GAS7000, UVItec Limited.  
Ice Machine     : AF 10, Scotsman.  
Incubators     : EN400, Nuve 
Orbital shaker    : Certomat S II, product# 886 252 4, B. Braun  
  Biotech International GmbH.  
Magnetic stirrer    : AGE 10.0164, VELP Scientifica srl.  
: ARE 10.0162, VELP Scientifica srl.  
Microscope     : BX60, Olympus Corporation.  
: CH60, Olympus Corporation.  
Microscope Camera    : RT Slider, Spot Diagnostic Instruments.  
Pipettes    : Pipetteman P10, P 100, P1000, Eppendorf  
pH meter     : MP 220, Mettler Toledo International Inc.  
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pH meter                                            : Inolab pH level 1, order #1A10-1113,  
 Wissenschaftlich-Technische Werkstätten  
 GmbH & Co KG.  
Power supply    : EC 250-90, E-C Apparatus.  
Pure water systems    : USF Elga UHQ-PS-MK3, Elga Labwater.  
Spectrophotometer    : DU530 Life Science UV/ Vis, Beckman.  
: UV-1601, Shimadzu Corporation.  
Sterilizer     : FN 500, Nuve.  
Transilluminator    : UV Transilluminator 2000, Catalog #170-  
  8110 EDU, Bio-Rad.  
Vortexing machine    : Reax Top, product #541-10000, Heidolph2.2 
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